BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register

NGEN

NervGen Pharma Corp. Common stock NASDAQ Listed Feb 8, 2021
$1.76
Pre-mkt $1.78 +1.14%
Mkt Cap $144.7M
52w Low $1.58 3.8% of range 52w High $6.30
50d MA $1.93 200d MA $3.23
P/E (TTM) —
EV/EBITDA —
P/B 36.6x
Debt/Equity 0.0x
ROE —
P/FCF -6.5x
RSI (14) 29.90
ATR (14) $0.13
Beta 0.99
50d MA $1.93
200d MA $3.23
Avg Volume 601.4K
NervGen Pharma Corp. is a clinical-stage biotechnology company developing therapies aimed at treating nerve damage and neurodegenerative conditions by targeting mechanisms that inhibit nervous system repair.
SIC Code
2834
CIK (SEC)
Phone
604-336-8089
1455 Bellevue Avenue, Suite 301 · West Vancouver, BC V7T 1C3 · CA
Data updated apr 26, 2026 2:55pm · Source: financialmodelingprep.com